Immunosuppressive effect of acute-phase reactant proteins in vitro and its relevance to cancer
Authors:
- 1 June 1982
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 13 (1) , 38-43
Abstract
Acute-phase reactant proteins reach abnormally high levels in patients with cancer, and correlate with the extent of disease. In this study, several acute-phase glycoproteins, and serum albumin as a control, were tested at different concentrations for their ability to modify the blastogenic response of lymphocytes from 30 normal donors to PHA and the chemotactic response of monocytes from 15 normal donors to casein. In high concentrations approximating those found in cancer patients, but not in normal concentrations, haptoglobin and fibrinogen inhibited both functions to different degrees. Orosomucoid inhibited only monocyte chemotaxis, while ceruloplasmin and α1-antitrypsin affected neither function. Increasing concentrations of PHA did not overcome the blocking effect of haptoglobin and fibrinogen on blastogenesis, suggesting that PHA-protein interaction was not responsible for the effect observed. The three proteins that did not suppress blastogenesis individually did so strongly when combined. It is suggested that these glycoproteins, synthesized by the liver in response to an inflammatory stimulus, may act as ‘non-specific blocking factors’ protecting tumors against the host's immunological attack. This non-specific blocking activity of the acute-phase proteins may contribute to the ‘immune escape’ of the tumor.Keywords
This publication has 18 references indexed in Scilit:
- Serum glycoproteins in cancer patients: First report of correlations within vitro andin vivo parameters of cellular immunityCancer, 1980
- Elevated serum Cu in Hodgkin's disease and inhibitory effects of ceruloplasmin on lymphocyte response in vitroEuropean Journal of Cancer (1965), 1980
- INVIVO AND INVITRO STUDIES ON NONSPECIFIC BLOCKING FACTORS OF HOST ORIGIN IN CANCER-PATIENTS - ROLE OF PLASMA EXCHANGE AS AN IMMUNOTHERAPEUTIC MODALITY1978
- Monocyte function in cancer patientsEuropean Journal of Cancer (1965), 1977
- Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymesBritish Journal of Cancer, 1977
- IMPROVEMENT OF PHYTOHEMAGGLUTININ RESPONSIVENESS OF LYMPHOCYTES FROM CANCER-PATIENTS AFTER WASHING INVITRO1977
- INTERACTIONS OF ALPHA1-ACID GLYCOPROTEIN WITH IMMUNE SYSTEM .1. PURIFICATION AND EFFECTS UPON LYMPHOCYTE RESPONSIVENESS1977
- Plasma Alpha-1-Antitrypsin Levels in Early and Late Carcinoma of the CervixOncology, 1976
- Serum haptoglobin in patients with ovarian malignancies.1971
- Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomasCellular Immunology, 1970